

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to dietary excess (GO:0002021) | 5.45969168 |
| 2 | glycerolipid catabolic process (GO:0046503) | 5.36166581 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 5.20074735 |
| 4 | fatty acid transmembrane transport (GO:1902001) | 5.01520094 |
| 5 | positive regulation of glomerulus development (GO:0090193) | 4.93375012 |
| 6 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.86295417 |
| 7 | lymph vessel development (GO:0001945) | 4.82845723 |
| 8 | negative regulation of amino acid transport (GO:0051956) | 4.58937811 |
| 9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.48951809 |
| 10 | lipid particle organization (GO:0034389) | 4.48334366 |
| 11 | carnitine shuttle (GO:0006853) | 4.45497491 |
| 12 | lipid storage (GO:0019915) | 4.44402420 |
| 13 | protein heterotrimerization (GO:0070208) | 4.28678105 |
| 14 | positive regulation of glycolytic process (GO:0045821) | 4.27853788 |
| 15 | regulation of gonadotropin secretion (GO:0032276) | 4.26129942 |
| 16 | fatty acid homeostasis (GO:0055089) | 4.17362655 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 4.08944967 |
| 18 | diacylglycerol metabolic process (GO:0046339) | 4.07456394 |
| 19 | regulation of lipoprotein metabolic process (GO:0050746) | 3.99913031 |
| 20 | negative regulation of appetite (GO:0032099) | 3.95472585 |
| 21 | negative regulation of response to food (GO:0032096) | 3.95472585 |
| 22 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.90381700 |
| 23 | negative regulation of macrophage differentiation (GO:0045650) | 3.86225163 |
| 24 | ethanol oxidation (GO:0006069) | 3.79169948 |
| 25 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.79031229 |
| 26 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.75141421 |
| 27 | * transcytosis (GO:0045056) | 3.73969308 |
| 28 | glycerol metabolic process (GO:0006071) | 3.66927746 |
| 29 | biotin metabolic process (GO:0006768) | 3.65471230 |
| 30 | fatty acid beta-oxidation (GO:0006635) | 3.62937942 |
| 31 | cardiac myofibril assembly (GO:0055003) | 3.60084189 |
| 32 | sarcomere organization (GO:0045214) | 3.58078473 |
| 33 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.57475938 |
| 34 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.57038954 |
| 35 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.55909221 |
| 36 | adult feeding behavior (GO:0008343) | 3.54282711 |
| 37 | glomerular filtration (GO:0003094) | 3.53405259 |
| 38 | cellular response to leptin stimulus (GO:0044320) | 3.51407352 |
| 39 | endothelium development (GO:0003158) | 3.51344536 |
| 40 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.45537160 |
| 41 | carnitine transmembrane transport (GO:1902603) | 3.42066563 |
| 42 | brown fat cell differentiation (GO:0050873) | 3.41108762 |
| 43 | surfactant homeostasis (GO:0043129) | 3.36102519 |
| 44 | myofibril assembly (GO:0030239) | 3.35279094 |
| 45 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.33279272 |
| 46 | negative regulation of granulocyte differentiation (GO:0030853) | 3.33114000 |
| 47 | heart trabecula formation (GO:0060347) | 3.32771515 |
| 48 | response to phenylpropanoid (GO:0080184) | 3.28913192 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.27120805 |
| 50 | plasma membrane repair (GO:0001778) | 3.26315235 |
| 51 | positive regulation of fatty acid oxidation (GO:0046321) | 3.25269517 |
| 52 | fatty acid oxidation (GO:0019395) | 3.24491605 |
| 53 | oxaloacetate metabolic process (GO:0006107) | 3.22801651 |
| 54 | regulation of glomerulus development (GO:0090192) | 3.22384826 |
| 55 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.21976129 |
| 56 | amino-acid betaine transport (GO:0015838) | 3.21610511 |
| 57 | carnitine transport (GO:0015879) | 3.21610511 |
| 58 | regulation of cholesterol storage (GO:0010885) | 3.19246358 |
| 59 | lipid oxidation (GO:0034440) | 3.18424847 |
| 60 | renal filtration (GO:0097205) | 3.16898202 |
| 61 | response to vitamin E (GO:0033197) | 3.15952000 |
| 62 | regulation of actin filament-based movement (GO:1903115) | 3.15397066 |
| 63 | detection of calcium ion (GO:0005513) | 3.14879006 |
| 64 | negative regulation of metanephros development (GO:0072217) | 3.14619286 |
| 65 | response to epinephrine (GO:0071871) | 3.11673229 |
| 66 | tricarboxylic acid cycle (GO:0006099) | 3.11572869 |
| 67 | fatty acid catabolic process (GO:0009062) | 3.11248994 |
| 68 | alditol metabolic process (GO:0019400) | 3.09762433 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 3.08287931 |
| 70 | response to leptin (GO:0044321) | 3.08264316 |
| 71 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.07722784 |
| 72 | regulation of fatty acid oxidation (GO:0046320) | 3.07709069 |
| 73 | regulation of lipid storage (GO:0010883) | 3.05671474 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.05154587 |
| 75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.05154587 |
| 76 | phosphatidic acid metabolic process (GO:0046473) | 3.05153979 |
| 77 | phosphatidic acid biosynthetic process (GO:0006654) | 3.05153979 |
| 78 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.04422488 |
| 79 | negative regulation of gluconeogenesis (GO:0045721) | 3.03321726 |
| 80 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.03292221 |
| 81 | response to nitrosative stress (GO:0051409) | 3.01919939 |
| 82 | primary alcohol metabolic process (GO:0034308) | 3.00009486 |
| 83 | ovulation from ovarian follicle (GO:0001542) | 2.99927249 |
| 84 | lymphangiogenesis (GO:0001946) | 2.98748913 |
| 85 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.97863082 |
| 86 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.97125477 |
| 87 | triglyceride catabolic process (GO:0019433) | 2.95893789 |
| 88 | positive regulation of lipid storage (GO:0010884) | 2.94040577 |
| 89 | polyol transport (GO:0015791) | 2.93837575 |
| 90 | chemical homeostasis within a tissue (GO:0048875) | 2.93321287 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 2.90048473 |
| 92 | somite development (GO:0061053) | 2.89130395 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 2.88328099 |
| 94 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.87310650 |
| 95 | retinol metabolic process (GO:0042572) | 2.87021534 |
| 96 | ethanol metabolic process (GO:0006067) | 2.86877016 |
| 97 | regulation of protein kinase A signaling (GO:0010738) | 2.85952366 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.85756595 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 2.85704313 |
| 100 | succinate metabolic process (GO:0006105) | 2.85319554 |
| 101 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.84868816 |
| 102 | angiogenesis involved in wound healing (GO:0060055) | 2.82027310 |
| 103 | regulation of receptor binding (GO:1900120) | 2.81873249 |
| 104 | triglyceride biosynthetic process (GO:0019432) | 2.81788530 |
| 105 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.81295751 |
| 106 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.81030896 |
| 107 | triglyceride metabolic process (GO:0006641) | 2.80177779 |
| 108 | branched-chain amino acid catabolic process (GO:0009083) | 2.79152068 |
| 109 | glomerular basement membrane development (GO:0032836) | 2.78827663 |
| 110 | glomerular visceral epithelial cell development (GO:0072015) | 2.77650779 |
| 111 | negative regulation of protein autophosphorylation (GO:0031953) | 2.76729981 |
| 112 | cGMP-mediated signaling (GO:0019934) | 2.76641871 |
| 113 | regulation of skeletal muscle contraction (GO:0014819) | 2.76238587 |
| 114 | neutral lipid biosynthetic process (GO:0046460) | 2.75978196 |
| 115 | acylglycerol biosynthetic process (GO:0046463) | 2.75978196 |
| 116 | actin-myosin filament sliding (GO:0033275) | 2.74777958 |
| 117 | muscle filament sliding (GO:0030049) | 2.74777958 |
| 118 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.74478206 |
| 119 | acylglycerol catabolic process (GO:0046464) | 2.72716299 |
| 120 | neutral lipid catabolic process (GO:0046461) | 2.72716299 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 2.72686015 |
| 122 | venous blood vessel morphogenesis (GO:0048845) | 2.72349026 |
| 123 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.71779892 |
| 124 | behavioral response to nicotine (GO:0035095) | 2.70438586 |
| 125 | negative regulation of lipid catabolic process (GO:0050995) | 2.70158419 |
| 126 | cellular response to vitamin (GO:0071295) | 2.67669353 |
| 127 | plasma lipoprotein particle clearance (GO:0034381) | 2.67542699 |
| 128 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.67296374 |
| 129 | lysine metabolic process (GO:0006553) | 2.67153992 |
| 130 | lysine catabolic process (GO:0006554) | 2.67153992 |
| 131 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.66718975 |
| 132 | cellular response to epinephrine stimulus (GO:0071872) | 2.66567340 |
| 133 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.65957368 |
| 134 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.65810711 |
| 135 | positive regulation of vasculogenesis (GO:2001214) | 2.65310498 |
| 136 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.65020533 |
| 137 | endocrine hormone secretion (GO:0060986) | 2.64585503 |
| 138 | cardiac muscle contraction (GO:0060048) | 2.64573666 |
| 139 | monocarboxylic acid catabolic process (GO:0072329) | 2.63850467 |
| 140 | regulation of relaxation of muscle (GO:1901077) | 2.63432390 |
| 141 | endothelial cell morphogenesis (GO:0001886) | 2.63203727 |
| 142 | branched-chain amino acid metabolic process (GO:0009081) | 2.62660178 |
| 143 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.62550905 |
| 144 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.62393497 |
| 145 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.61862862 |
| 146 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.61594144 |
| 147 | white fat cell differentiation (GO:0050872) | 2.60459384 |
| 148 | valine metabolic process (GO:0006573) | 2.55580062 |
| 149 | blood vessel endothelial cell migration (GO:0043534) | 2.54813342 |
| 150 | cardiac muscle hypertrophy (GO:0003300) | 2.53733566 |
| 151 | regulation of endothelial cell differentiation (GO:0045601) | 2.53262184 |
| 152 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.52485155 |
| 153 | quaternary ammonium group transport (GO:0015697) | 2.51680725 |
| 154 | intracellular lipid transport (GO:0032365) | 2.47813628 |
| 155 | regulation of sarcomere organization (GO:0060297) | 2.47407424 |
| 156 | creatine metabolic process (GO:0006600) | 2.47021480 |
| 157 | phagocytosis, recognition (GO:0006910) | 2.46796667 |
| 158 | actin-mediated cell contraction (GO:0070252) | 2.45466121 |
| 159 | long-chain fatty acid transport (GO:0015909) | 2.45400252 |
| 160 | regulation of p38MAPK cascade (GO:1900744) | 2.44858568 |
| 161 | NADH metabolic process (GO:0006734) | 2.44648304 |
| 162 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.44341896 |
| 163 | adult heart development (GO:0007512) | 2.43717357 |
| 164 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.43623134 |
| 165 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.43301709 |
| 166 | carnitine metabolic process (GO:0009437) | 2.42794425 |
| 167 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42627259 |
| 168 | acylglycerol homeostasis (GO:0055090) | 2.42530110 |
| 169 | triglyceride homeostasis (GO:0070328) | 2.42530110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.69995077 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34307266 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87876799 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.77242124 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.40967810 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.38290166 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.35175363 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.34418926 |
| 9 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19524300 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15929543 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11135757 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97897483 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90313829 |
| 14 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86914539 |
| 15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86247731 |
| 16 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.79136637 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75303242 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72016533 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.71643056 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71594953 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.71282728 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.71282728 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.64495006 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.64131414 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62782779 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60476498 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60457011 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58643732 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53598931 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52574464 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52091511 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52091511 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48882356 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44603301 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43171754 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42404342 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40017958 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38903147 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37693715 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36999425 |
| 41 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.36115616 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32145097 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.31283377 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29487381 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28886559 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27611249 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26559439 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26559439 |
| 49 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25983769 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.25047381 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23596002 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22671816 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22287687 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22284072 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.22136271 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22075320 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21701837 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20739841 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20732638 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20136543 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19810998 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19330398 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18816285 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18274673 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16983908 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15257810 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14850426 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14706590 |
| 69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13916456 |
| 70 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13054647 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11399458 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11283171 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10878449 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10878449 |
| 75 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09893866 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09059329 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08798498 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08561651 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06875892 |
| 80 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.05915496 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.05800567 |
| 82 | CBP_21632823_ChIP-Seq_H3396_Human | 1.05617770 |
| 83 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05412702 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05158244 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05017136 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04667299 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04025893 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03894302 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03740825 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03236291 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03104780 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02029120 |
| 93 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01730842 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00980172 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00846489 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00846489 |
| 97 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00731629 |
| 98 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.00482858 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00462588 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00462588 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00342198 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00152917 |
| 103 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00006974 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99773624 |
| 105 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99617876 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99039816 |
| 107 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98843225 |
| 108 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97510306 |
| 109 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97064236 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96536097 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96493191 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96322838 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95759717 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95739543 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95275386 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95200569 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94874965 |
| 118 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94560630 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94371595 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92967924 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92930173 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92268824 |
| 123 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91797957 |
| 124 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91772648 |
| 125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91689825 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91433917 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91286378 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91214407 |
| 129 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91151555 |
| 130 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90947918 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90134158 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90107286 |
| 133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90095324 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90016653 |
| 135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89993003 |
| 136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89867104 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89599043 |
| 138 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86750582 |
| 139 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86565817 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86372444 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85051714 |
| 142 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84650152 |
| 143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83260591 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82155046 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81389459 |
| 146 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79402412 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79178973 |
| 148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78656609 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75839090 |
| 150 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75626765 |
| 151 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75576558 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74861605 |
| 153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.74762979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.57166336 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.50068652 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.81680999 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.55532599 |
| 5 | MP0004130_abnormal_muscle_cell | 3.52992424 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.50398740 |
| 7 | MP0000751_myopathy | 3.26924703 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 3.24936309 |
| 9 | MP0003724_increased_susceptibility_to | 3.18860538 |
| 10 | MP0003646_muscle_fatigue | 2.84875634 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.84151967 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.73961600 |
| 13 | MP0003828_pulmonary_edema | 2.68696794 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.55020160 |
| 15 | MP0003959_abnormal_lean_body | 2.41786173 |
| 16 | MP0004272_abnormal_basement_membrane | 2.41061554 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.39240177 |
| 18 | MP0005330_cardiomyopathy | 2.36787525 |
| 19 | MP0003011_delayed_dark_adaptation | 2.29002176 |
| 20 | MP0006138_congestive_heart_failure | 2.19378221 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.09186819 |
| 22 | MP0000749_muscle_degeneration | 2.08554077 |
| 23 | MP0005375_adipose_tissue_phenotype | 2.07048547 |
| 24 | MP0002972_abnormal_cardiac_muscle | 2.03090897 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.02575114 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 2.00986510 |
| 27 | MP0000750_abnormal_muscle_regeneration | 1.99448980 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.97134082 |
| 29 | MP0005385_cardiovascular_system_phenoty | 1.97134082 |
| 30 | MP0005620_abnormal_muscle_contractility | 1.94347905 |
| 31 | MP0002970_abnormal_white_adipose | 1.88708572 |
| 32 | MP0003186_abnormal_redox_activity | 1.86809593 |
| 33 | MP0004484_altered_response_of | 1.82096189 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.80911813 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.80230151 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.79174798 |
| 37 | MP0005360_urolithiasis | 1.79008841 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.73938613 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.72405166 |
| 40 | MP0005448_abnormal_energy_balance | 1.72009226 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.65632035 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.63251191 |
| 43 | MP0000343_altered_response_to | 1.57652915 |
| 44 | MP0004085_abnormal_heartbeat | 1.55907901 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.55785098 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.54865822 |
| 47 | MP0002971_abnormal_brown_adipose | 1.54050559 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.49798852 |
| 49 | MP0005165_increased_susceptibility_to | 1.45441118 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.44379334 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.43574352 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.41378948 |
| 53 | MP0005365_abnormal_bile_salt | 1.40133833 |
| 54 | MP0005452_abnormal_adipose_tissue | 1.40003594 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.37768478 |
| 56 | MP0002106_abnormal_muscle_physiology | 1.30221908 |
| 57 | MP0000230_abnormal_systemic_arterial | 1.28264432 |
| 58 | MP0004147_increased_porphyrin_level | 1.27682256 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.24429861 |
| 60 | MP0002933_joint_inflammation | 1.21876924 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.20053577 |
| 62 | MP0001661_extended_life_span | 1.19795966 |
| 63 | MP0001764_abnormal_homeostasis | 1.18748382 |
| 64 | MP0003868_abnormal_feces_composition | 1.18465173 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.16969152 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.12162402 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.12018831 |
| 68 | MP0003690_abnormal_glial_cell | 1.11996590 |
| 69 | MP0005369_muscle_phenotype | 1.09822786 |
| 70 | MP0003279_aneurysm | 1.05692853 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 1.04702128 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.03209807 |
| 73 | MP0009115_abnormal_fat_cell | 1.02665014 |
| 74 | MP0005334_abnormal_fat_pad | 1.02014876 |
| 75 | MP0000767_abnormal_smooth_muscle | 1.01422475 |
| 76 | MP0003252_abnormal_bile_duct | 1.00313325 |
| 77 | MP0005266_abnormal_metabolism | 0.99873267 |
| 78 | MP0005647_abnormal_sex_gland | 0.98321452 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.97322692 |
| 80 | MP0005535_abnormal_body_temperature | 0.95990792 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.94222218 |
| 82 | MP0002269_muscular_atrophy | 0.92953300 |
| 83 | MP0005332_abnormal_amino_acid | 0.90898621 |
| 84 | MP0000249_abnormal_blood_vessel | 0.89414964 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88570477 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.88458122 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.88366226 |
| 88 | MP0003195_calcinosis | 0.87968911 |
| 89 | MP0002128_abnormal_blood_circulation | 0.86787434 |
| 90 | MP0001984_abnormal_olfaction | 0.86157679 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.84973812 |
| 92 | MP0000747_muscle_weakness | 0.84567820 |
| 93 | MP0005451_abnormal_body_composition | 0.84061393 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.83351140 |
| 95 | MP0008004_abnormal_stomach_pH | 0.82105339 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.80327935 |
| 97 | MP0004510_myositis | 0.77683261 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.77161509 |
| 99 | MP0001851_eye_inflammation | 0.77141408 |
| 100 | MP0000609_abnormal_liver_physiology | 0.77073825 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.75777946 |
| 102 | MP0003948_abnormal_gas_homeostasis | 0.74282754 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.73919538 |
| 104 | MP0005409_darkened_coat_color | 0.73847663 |
| 105 | MP0003953_abnormal_hormone_level | 0.72759781 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.72682570 |
| 107 | MP0005275_abnormal_skin_tensile | 0.72243654 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.70246614 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.69941498 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.69776399 |
| 111 | MP0000266_abnormal_heart_morphology | 0.69278986 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.68687383 |
| 113 | MP0002102_abnormal_ear_morphology | 0.68416945 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.68389004 |
| 115 | MP0003045_fibrosis | 0.68143202 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.64623186 |
| 117 | MP0004924_abnormal_behavior | 0.63638836 |
| 118 | MP0005386_behavior/neurological_phenoty | 0.63638836 |
| 119 | MP0005164_abnormal_response_to | 0.63631335 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.63233808 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.62078478 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.61771452 |
| 123 | MP0002796_impaired_skin_barrier | 0.61300206 |
| 124 | MP0008872_abnormal_physiological_respon | 0.61222046 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60698338 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.60374070 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.60170607 |
| 128 | MP0001756_abnormal_urination | 0.59713086 |
| 129 | MP0001614_abnormal_blood_vessel | 0.59314214 |
| 130 | MP0005253_abnormal_eye_physiology | 0.57680343 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57610872 |
| 132 | MP0004043_abnormal_pH_regulation | 0.56175057 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.53583341 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.47856252 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.46760969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ventricular tachycardia (HP:0004756) | 5.36268138 |
| 2 | Sudden death (HP:0001699) | 5.32491544 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.21428895 |
| 4 | Atrial fibrillation (HP:0005110) | 4.47234641 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.45460942 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.44270336 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.21972885 |
| 8 | Exercise-induced myalgia (HP:0003738) | 4.14662883 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 4.07494453 |
| 10 | Difficulty running (HP:0009046) | 4.06754866 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 4.05906147 |
| 12 | Supraventricular arrhythmia (HP:0005115) | 3.95318983 |
| 13 | Lipoatrophy (HP:0100578) | 3.94861839 |
| 14 | Increased connective tissue (HP:0009025) | 3.94809269 |
| 15 | Supraventricular tachycardia (HP:0004755) | 3.87604114 |
| 16 | Myoglobinuria (HP:0002913) | 3.75456001 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.41378463 |
| 18 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.38898129 |
| 19 | Abnormality of alanine metabolism (HP:0010916) | 3.38898129 |
| 20 | Hyperalaninemia (HP:0003348) | 3.38898129 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.36391709 |
| 22 | Hyperglycinuria (HP:0003108) | 3.35892125 |
| 23 | Decreased circulating renin level (HP:0003351) | 3.31155501 |
| 24 | Syncope (HP:0001279) | 3.28609219 |
| 25 | Ketoacidosis (HP:0001993) | 3.25344026 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23371359 |
| 27 | Polycythemia (HP:0001901) | 3.21720958 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.18906788 |
| 29 | Insulin resistance (HP:0000855) | 3.17185200 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.13698322 |
| 31 | Prolonged QT interval (HP:0001657) | 3.11695606 |
| 32 | Adactyly (HP:0009776) | 3.07506804 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 3.03447565 |
| 34 | Palpitations (HP:0001962) | 3.00522478 |
| 35 | Ketosis (HP:0001946) | 2.91802108 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.85697014 |
| 37 | EMG: myopathic abnormalities (HP:0003458) | 2.84671713 |
| 38 | Dicarboxylic aciduria (HP:0003215) | 2.83000349 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83000349 |
| 40 | Epidermoid cyst (HP:0200040) | 2.82599365 |
| 41 | Deep venous thrombosis (HP:0002625) | 2.81468515 |
| 42 | Oligomenorrhea (HP:0000876) | 2.75988797 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.75675153 |
| 44 | Myotonia (HP:0002486) | 2.73974478 |
| 45 | Frequent falls (HP:0002359) | 2.73240702 |
| 46 | Broad metatarsal (HP:0001783) | 2.72975843 |
| 47 | Polyphagia (HP:0002591) | 2.72331613 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.71894983 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71894983 |
| 50 | Acanthosis nigricans (HP:0000956) | 2.67586253 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.66825333 |
| 52 | Bundle branch block (HP:0011710) | 2.66714927 |
| 53 | Rimmed vacuoles (HP:0003805) | 2.66201785 |
| 54 | Atrioventricular block (HP:0001678) | 2.64344287 |
| 55 | Polydipsia (HP:0001959) | 2.63732733 |
| 56 | Abnormal drinking behavior (HP:0030082) | 2.63732733 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.62273274 |
| 58 | Heart block (HP:0012722) | 2.61689186 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.58750903 |
| 60 | Prominent supraorbital ridges (HP:0000336) | 2.57181190 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.56792397 |
| 62 | Cerebral hemorrhage (HP:0001342) | 2.55552339 |
| 63 | Hyperammonemia (HP:0001987) | 2.55074545 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 2.53011640 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.51219011 |
| 66 | Abnormal atrioventricular conduction (HP:0005150) | 2.48851350 |
| 67 | Subaortic stenosis (HP:0001682) | 2.48201137 |
| 68 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.48201137 |
| 69 | Muscle stiffness (HP:0003552) | 2.46888850 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.41878767 |
| 71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.41178031 |
| 72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.40183769 |
| 73 | Ventricular arrhythmia (HP:0004308) | 2.40102910 |
| 74 | Neck muscle weakness (HP:0000467) | 2.36765262 |
| 75 | Lymphangioma (HP:0100764) | 2.35686182 |
| 76 | Inability to walk (HP:0002540) | 2.32469216 |
| 77 | Increased muscle lipid content (HP:0009058) | 2.32236970 |
| 78 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.31022392 |
| 79 | Hypertriglyceridemia (HP:0002155) | 2.29688003 |
| 80 | Complement deficiency (HP:0004431) | 2.28621118 |
| 81 | Esophageal varix (HP:0002040) | 2.27549375 |
| 82 | Nemaline bodies (HP:0003798) | 2.26256606 |
| 83 | Difficulty climbing stairs (HP:0003551) | 2.24537575 |
| 84 | Spontaneous hematomas (HP:0007420) | 2.24157290 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22103537 |
| 86 | Joint hemorrhage (HP:0005261) | 2.21119046 |
| 87 | Testicular atrophy (HP:0000029) | 2.20775674 |
| 88 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20224517 |
| 89 | Congenital stationary night blindness (HP:0007642) | 2.20045750 |
| 90 | Abnormality of the ischium (HP:0003174) | 2.19921867 |
| 91 | Bone cyst (HP:0012062) | 2.18944767 |
| 92 | Hypoplastic ischia (HP:0003175) | 2.18097203 |
| 93 | Pancreatic cysts (HP:0001737) | 2.17370247 |
| 94 | Hypoplasia of the iris (HP:0007676) | 2.16835962 |
| 95 | Hepatic necrosis (HP:0002605) | 2.15277571 |
| 96 | Xanthomatosis (HP:0000991) | 2.12897359 |
| 97 | Pulmonary artery stenosis (HP:0004415) | 2.11725685 |
| 98 | Abnormality of the renal collecting system (HP:0004742) | 2.11158478 |
| 99 | Hemorrhage of the eye (HP:0011885) | 2.10692392 |
| 100 | Nephronophthisis (HP:0000090) | 2.10630335 |
| 101 | Skin nodule (HP:0200036) | 2.10159018 |
| 102 | Generalized aminoaciduria (HP:0002909) | 2.09234164 |
| 103 | Areflexia of lower limbs (HP:0002522) | 2.07962208 |
| 104 | Mesangial abnormality (HP:0001966) | 2.02370151 |
| 105 | Increased circulating renin level (HP:0000848) | 2.01956214 |
| 106 | Broad-based gait (HP:0002136) | 2.01802895 |
| 107 | Nausea (HP:0002018) | 2.01622068 |
| 108 | Duplicated collecting system (HP:0000081) | 2.01464865 |
| 109 | Attenuation of retinal blood vessels (HP:0007843) | 2.00897405 |
| 110 | Generalized muscle weakness (HP:0003324) | 2.00368942 |
| 111 | Increased corneal curvature (HP:0100692) | 1.99892725 |
| 112 | Keratoconus (HP:0000563) | 1.99892725 |
| 113 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99706410 |
| 114 | Pigmentary retinal degeneration (HP:0001146) | 1.99641926 |
| 115 | Cerebral edema (HP:0002181) | 1.99293719 |
| 116 | Abnormal EKG (HP:0003115) | 1.98960774 |
| 117 | Hematochezia (HP:0002573) | 1.98416727 |
| 118 | Mitochondrial inheritance (HP:0001427) | 1.97442869 |
| 119 | Large for gestational age (HP:0001520) | 1.96812394 |
| 120 | Renal Fanconi syndrome (HP:0001994) | 1.96714183 |
| 121 | Toxemia of pregnancy (HP:0100603) | 1.96091249 |
| 122 | Hepatocellular necrosis (HP:0001404) | 1.95848575 |
| 123 | Renal cortical cysts (HP:0000803) | 1.95097512 |
| 124 | Prolonged partial thromboplastin time (HP:0003645) | 1.94936403 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94313661 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.94086960 |
| 127 | Infantile muscular hypotonia (HP:0008947) | 1.92953270 |
| 128 | Spinal rigidity (HP:0003306) | 1.92348916 |
| 129 | Abnormal hemoglobin (HP:0011902) | 1.92204193 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91996157 |
| 131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91066551 |
| 132 | Axonal loss (HP:0003447) | 1.90397134 |
| 133 | Exertional dyspnea (HP:0002875) | 1.90387476 |
| 134 | Increased serum pyruvate (HP:0003542) | 1.89578130 |
| 135 | Acute necrotizing encephalopathy (HP:0006965) | 1.88872407 |
| 136 | Myocardial infarction (HP:0001658) | 1.88556260 |
| 137 | Polyuria (HP:0000103) | 1.87086566 |
| 138 | Abnormal urine output (HP:0012590) | 1.86649178 |
| 139 | Facial diplegia (HP:0001349) | 1.86562990 |
| 140 | Gowers sign (HP:0003391) | 1.86345703 |
| 141 | Opisthotonus (HP:0002179) | 1.86282375 |
| 142 | True hermaphroditism (HP:0010459) | 1.85569460 |
| 143 | Metabolic acidosis (HP:0001942) | 1.85495665 |
| 144 | Abnormality of midbrain morphology (HP:0002418) | 1.85049430 |
| 145 | Molar tooth sign on MRI (HP:0002419) | 1.85049430 |
| 146 | Hyperglycemia (HP:0003074) | 1.84250072 |
| 147 | Metaphyseal dysplasia (HP:0100255) | 1.84203442 |
| 148 | Back pain (HP:0003418) | 1.83449812 |
| 149 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82588160 |
| 150 | Pancreatic fibrosis (HP:0100732) | 1.82516326 |
| 151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81421680 |
| 152 | Hyperglycinemia (HP:0002154) | 1.81295125 |
| 153 | Nonimmune hydrops fetalis (HP:0001790) | 1.81203223 |
| 154 | Nephritis (HP:0000123) | 1.79251548 |
| 155 | Cavernous hemangioma (HP:0001048) | 1.78928486 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.77150065 |
| 157 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.77107351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.59123294 |
| 2 | KDR | 4.93440984 |
| 3 | FRK | 4.07799017 |
| 4 | TTN | 3.02125935 |
| 5 | TGFBR2 | 2.75593892 |
| 6 | MYLK | 2.57224298 |
| 7 | WNK4 | 2.39350237 |
| 8 | MAPKAPK3 | 2.27808244 |
| 9 | BCKDK | 2.24794113 |
| 10 | INSRR | 2.17325697 |
| 11 | PHKG1 | 2.07560511 |
| 12 | PHKG2 | 2.07560511 |
| 13 | CAMKK2 | 2.01808274 |
| 14 | EPHB2 | 2.01789847 |
| 15 | STK39 | 2.01071257 |
| 16 | MAP4K2 | 1.98789704 |
| 17 | OBSCN | 1.94474470 |
| 18 | ADRBK2 | 1.92177677 |
| 19 | PDK2 | 1.85839240 |
| 20 | CAMK1D | 1.85548749 |
| 21 | PDK4 | 1.72059318 |
| 22 | PDK3 | 1.72059318 |
| 23 | LMTK2 | 1.65757499 |
| 24 | ADRBK1 | 1.64628738 |
| 25 | RIPK1 | 1.63743808 |
| 26 | SIK1 | 1.62288560 |
| 27 | DMPK | 1.61292602 |
| 28 | CAMK1G | 1.54120515 |
| 29 | GRK5 | 1.52947698 |
| 30 | PIK3CA | 1.52651062 |
| 31 | KIT | 1.47660051 |
| 32 | WNK3 | 1.41736090 |
| 33 | EPHB1 | 1.39306604 |
| 34 | OXSR1 | 1.33552955 |
| 35 | BLK | 1.32100170 |
| 36 | ZAK | 1.30415259 |
| 37 | PRKAA2 | 1.27847845 |
| 38 | MAPK13 | 1.25390213 |
| 39 | TXK | 1.25018413 |
| 40 | MAPK12 | 1.20982873 |
| 41 | TRIB3 | 1.15943774 |
| 42 | NUAK1 | 1.15584005 |
| 43 | ERN1 | 1.14551677 |
| 44 | TGFBR1 | 1.14526281 |
| 45 | PTK2B | 1.14132686 |
| 46 | NLK | 1.11570100 |
| 47 | STK38L | 1.09951812 |
| 48 | DDR2 | 1.09459482 |
| 49 | PRKD1 | 1.09219034 |
| 50 | TLK1 | 1.08873043 |
| 51 | FGFR4 | 1.07617436 |
| 52 | PKN1 | 1.05323882 |
| 53 | FER | 1.04962554 |
| 54 | LATS1 | 1.04593677 |
| 55 | ABL2 | 1.03688995 |
| 56 | GRK7 | 1.02710431 |
| 57 | IRAK3 | 1.00216807 |
| 58 | ACVR1B | 0.97157546 |
| 59 | JAK1 | 0.96965526 |
| 60 | GRK1 | 0.96137095 |
| 61 | CASK | 0.93004464 |
| 62 | PRKG1 | 0.92086443 |
| 63 | MAP2K3 | 0.90916069 |
| 64 | MAPKAPK5 | 0.85858040 |
| 65 | MAP3K3 | 0.85487643 |
| 66 | MAP3K7 | 0.85370443 |
| 67 | MAP3K14 | 0.80682401 |
| 68 | PINK1 | 0.79389080 |
| 69 | ERBB3 | 0.77227526 |
| 70 | MARK1 | 0.76055318 |
| 71 | PDGFRA | 0.72381149 |
| 72 | CAMK4 | 0.70240080 |
| 73 | CSK | 0.69739164 |
| 74 | PAK3 | 0.69356616 |
| 75 | FGFR2 | 0.67523867 |
| 76 | TEC | 0.67029838 |
| 77 | PDPK1 | 0.65556371 |
| 78 | IRAK1 | 0.64906844 |
| 79 | MST1R | 0.64692550 |
| 80 | PRKCE | 0.64638120 |
| 81 | MUSK | 0.63977922 |
| 82 | PRKAA1 | 0.62901666 |
| 83 | MAPK15 | 0.61565788 |
| 84 | EPHA3 | 0.60866442 |
| 85 | TRPM7 | 0.60372497 |
| 86 | MAPK7 | 0.60028307 |
| 87 | PTK6 | 0.58373679 |
| 88 | PIK3CG | 0.58001892 |
| 89 | PRKCH | 0.57458051 |
| 90 | CAMK1 | 0.57265759 |
| 91 | FGFR3 | 0.56246969 |
| 92 | TNK2 | 0.54987655 |
| 93 | STK3 | 0.54229248 |
| 94 | FLT3 | 0.54185205 |
| 95 | JAK2 | 0.53530593 |
| 96 | BMPR1B | 0.53118014 |
| 97 | ROCK1 | 0.50839607 |
| 98 | CAMK2D | 0.50742047 |
| 99 | WNK1 | 0.50615027 |
| 100 | MAP3K4 | 0.50413875 |
| 101 | BCR | 0.50042884 |
| 102 | CCNB1 | 0.48421997 |
| 103 | GSK3A | 0.47512630 |
| 104 | MARK2 | 0.47509961 |
| 105 | MAP2K6 | 0.47503163 |
| 106 | ABL1 | 0.46575154 |
| 107 | ITK | 0.45118064 |
| 108 | CAMK2A | 0.44571535 |
| 109 | MKNK2 | 0.44526846 |
| 110 | JAK3 | 0.43044374 |
| 111 | PRKCG | 0.42163383 |
| 112 | IGF1R | 0.41170285 |
| 113 | TAOK3 | 0.40899911 |
| 114 | PRKACG | 0.40194937 |
| 115 | DAPK2 | 0.39905858 |
| 116 | PRKG2 | 0.39741453 |
| 117 | CDK9 | 0.38093826 |
| 118 | PDK1 | 0.37170854 |
| 119 | PDGFRB | 0.37016119 |
| 120 | FES | 0.36427056 |
| 121 | MET | 0.36093042 |
| 122 | MAPK4 | 0.35917507 |
| 123 | CDC42BPA | 0.35292134 |
| 124 | PRKACA | 0.35098283 |
| 125 | MAP2K1 | 0.34399047 |
| 126 | PRKD2 | 0.34100669 |
| 127 | RPS6KA3 | 0.33534410 |
| 128 | MAP3K6 | 0.33415629 |
| 129 | PKN2 | 0.32472424 |
| 130 | PRKCQ | 0.32307170 |
| 131 | PRKACB | 0.32258860 |
| 132 | MAP3K13 | 0.32108087 |
| 133 | EIF2AK2 | 0.31923725 |
| 134 | MAP3K1 | 0.31810715 |
| 135 | MAP2K4 | 0.31351331 |
| 136 | MAPK3 | 0.30517365 |
| 137 | PRKCA | 0.29901124 |
| 138 | STK24 | 0.29691650 |
| 139 | SGK1 | 0.26723659 |
| 140 | STK11 | 0.26512325 |
| 141 | TYK2 | 0.26087068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.48808213 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.14164613 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.10140996 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.95322154 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.86171601 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.75845179 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.53309021 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02226887 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.99544233 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.97951980 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95120212 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91605749 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.90709001 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.79126847 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76695801 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69874088 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69276269 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68664007 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64253633 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55359767 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.54870135 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53333013 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49124885 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45927812 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.45578414 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41637492 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.39756259 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38354158 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36456575 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.35277705 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31664120 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31059643 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21505801 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18535067 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10260444 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09061546 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08708964 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04079339 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.04047541 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03961397 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01310716 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.00888133 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00718423 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97677306 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 0.94128353 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 0.91654046 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91227855 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89341235 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88982494 |
| 50 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86163035 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85980878 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85831047 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.84662488 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.83598244 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82897903 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.81292694 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.79776823 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78980120 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78339537 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78109130 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.77543743 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76275705 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74000455 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73893526 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72446069 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70275872 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70228495 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70118925 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69650986 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68980533 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67951883 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66973930 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66190117 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64388923 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62854407 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60562380 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60003705 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59392433 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59125117 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58733438 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58173670 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57296705 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54629433 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52599417 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52558791 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52279161 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51515832 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.51486937 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50433960 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50088458 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49943163 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49608224 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48029951 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.47407333 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.47287433 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46581248 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46354722 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45478136 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44736092 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44640773 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44574153 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.42982688 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42043228 |
| 104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41575988 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40721407 |
| 106 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39767959 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39661362 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39046609 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38791702 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38296591 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.38150298 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37816580 |
| 113 | Protein export_Homo sapiens_hsa03060 | 0.37650053 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37397515 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36867244 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36524541 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.35813919 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33591603 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33234437 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32774986 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32012059 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29651885 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29461731 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28820593 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27725731 |
| 126 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27188698 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27168565 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25547276 |
| 129 | Salivary secretion_Homo sapiens_hsa04970 | 0.25040581 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.24263626 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23104673 |

